ARCHIVES

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

Report on Carcinogens Lists Estrogen, UV Light, Wood Dust;

January 10, 2003

CIDAC Bids Not Limited To Cancer Research Centers

January 17, 1975

Herberman: Progress Made To Stabilize NSABP

September 9, 1994

DCPC Board Agrees to Commit $62 Million To Trials Of Prostate, Lung, Colorectal Cancer Screening

October 20, 1989

Judge Rules FDA Can’t Enforce Pediatric Rule

October 25, 2002

Drug Shortages: Institutions Report Halting Enrollment in Clinical Trials

March 22, 2013